- Analysis of Semiology, Lesion Topography and Treatment Outcomes: A Prospective Study on Post Thalamic Stroke Holmes Tremor
-
Datta AK, Mukherjee A, Malakar S, Biswas A
- KMID: 2551213
- J Mov Disord.
- 2024 Jan;17(1):71-81.
- doi: 10.14802/jmd.23095
Objective Holmes tremor (HT) comprises rest, postural and intention tremor subtypes, usually involving both proximal and distal musculature. Perturbations of nigro-striatal pathways might be fundamental in the pathogenesis of HT... -
- CITED
-
- Close
- SHARE
-
- Close
- A Network Meta-Analysis Comparing Osteoporotic Fracture among Different Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation
-
Khanra D, Mukherjee A, Deshpande S, Khan H, Kathuria S, Kella D, Padmanabhan D
- KMID: 2516596
- J Bone Metab.
- 2021 May;28(2):139-150.
- doi: 10.11005/jbm.2021.28.2.139
Background: There are limited studies comparing the risk of osteoporosis and fractures between different direct oral anticoagulants (DOACs) and vitamin K antagonists (VKA) in non-valvular atrial fibrillation (AF). Using a... -
- CITED
-
- Close
- SHARE
-
- Close
- Rhythm Control of Persistent Atrial Fibrillation in Systolic Heart Failure: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
-
Khanra D, Deshpande S, Mukherjee A, Mohan S, Khan H, Kathuria S, Kella D, Padmanabhan D
- KMID: 2532573
- Int J Heart Fail.
- 2021 Jul;3(3):179-193.
- doi: 10.36628/ijhf.2021.0008
Background and Objectives: Persistent atrial fibrillation (PeAF) with heart failure (HF) arguably constitutes the sickest subset of atrial fibrillation (AF) patients. Methods: A systematic search was made in PubMed, Embase, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
-
Boonsri B, Yacqub-Usman K, Thintharua P, Myint KZ, Sae-Lao T, Collier P, Suriyonplengsaeng C, Larbcharoensub N, Balasubramanian B, Venkatraman S, Egbuniwe IU, Gomez D, Mukherjee A, Kumkate S, Janvilisri T, Zaitoun AM, Kuakpaetoon T, Tohtong R, Grabowska AM, Bates DO, Wongprasert K
- KMID: 2514927
- Cancer Res Treat.
- 2021 Apr;53(2):457-470.
- doi: 10.4143/crt.2020.585
Purpose The potential of members of the epidermal growth factor receptor (ErbB) family as drug targets in cholangiocarcinoma (CCA) has not been extensively addressed. Although phase III clinical trials showed... -
- CITED
-
- Close
- SHARE
-
- Close
